Karah Herdman Parschauer
General Counsel, Ultragenyx Pharmaceutical Inc.
Companies
- Tenaya Therapeutics, Inc.Board member Dec 23, 2021 to now1
- Evolus, Inc.Board member Jul 17, 2019 to now2
- Ultragenyx Pharmaceutical Inc.General counsel Jun 22, 2016 to now3
- Anebulo Pharmaceuticals, Inc.Board member May 6, 2021 to Oct 3, 20224
- Arcturus TherapeuticsBoard member Jun 26, 2019 to Jun 22, 20215
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Ultragenyx Pharmaceutical Inc. RARE92,562 shares6$1.4M at $14.96Aug 3, 2026
- Evolus, Inc. EOLS77,742 shares7$562.1K at $7.23Feb 17, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 3, 2026Sold 1,900 shares at $24.92 of Ultragenyx Pharmaceutical Inc.6
- Jun 15, 2026Sold 1,899 shares at $24.62 of Ultragenyx Pharmaceutical Inc.8
- Apr 16, 2026Granted 28,895 shares of Ultragenyx Pharmaceutical Inc.9
- Mar 10, 2026Sold 3,508 shares at $22.67 of Ultragenyx Pharmaceutical Inc.10
- Mar 6, 2026Sold 6,018 shares at $21.40 of Ultragenyx Pharmaceutical Inc.10
- Mar 2, 2026Sold 8,135 shares at $22.80 of Ultragenyx Pharmaceutical Inc.11
- Mar 1, 2026Granted 11,137 shares of Ultragenyx Pharmaceutical Inc.11
- Feb 17, 2026Granted 45,559 shares of Evolus, Inc.7
- Sep 12, 2025Sold 2,450 shares at $31.17 of Ultragenyx Pharmaceutical Inc.12
- Mar 12, 2025Sold 12,888 shares at $12.99 of Evolus, Inc.13
- Mar 7, 2025Granted 7,364 shares of Evolus, Inc.14
- Mar 3, 2025Sold 12,846 shares at $42.10 of Ultragenyx Pharmaceutical Inc.15
- Mar 1, 2025Granted 14,494 shares of Ultragenyx Pharmaceutical Inc.16
- Mar 1, 2025Granted 18,443 shares of Ultragenyx Pharmaceutical Inc.15
- Feb 27, 2025Sold 760 shares at $42.75 of Ultragenyx Pharmaceutical Inc.16
- Feb 27, 2025Sold 2,230 shares at $42.93 of Ultragenyx Pharmaceutical Inc.16
- Jun 12, 2024Sold 9,806 shares at $45.00 of Ultragenyx Pharmaceutical Inc.17
- Mar 1, 2024Sold 3,756 shares at $53.76 of Ultragenyx Pharmaceutical Inc.18
- Mar 1, 2024Granted 957 shares of Ultragenyx Pharmaceutical Inc.18
- Mar 1, 2024Granted 17,800 shares of Ultragenyx Pharmaceutical Inc.18
- Feb 7, 2024Granted 6,464 shares of Evolus, Inc.19
- Jan 30, 2024Sold 11,931 shares at $13.14 of Evolus, Inc.20
- May 4, 2023Sold 4,378 shares at $45.00 of Ultragenyx Pharmaceutical Inc.21
- Mar 1, 2023Sold 3,161 shares at $45.25 of Ultragenyx Pharmaceutical Inc.22
- Mar 1, 2023Granted 22,000 shares of Ultragenyx Pharmaceutical Inc.22
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGAREvolus, Inc., Board member
- 3
- 4
- 5SEC EDGARArcturus Therapeutics, Board member
- 6
- 7
- 8SEC EDGARForm 4 filed Jun 15, 2026
- 9SEC EDGARForm 4 filed Apr 20, 2026
- 10SEC EDGARForm 4 filed Mar 10, 2026
- 11SEC EDGARForm 4 filed Mar 3, 2026
- 12SEC EDGARForm 4 filed Sep 12, 2025
- 13SEC EDGARForm 4 filed Mar 14, 2025
- 14SEC EDGARForm 4 filed Mar 11, 2025
- 15SEC EDGARForm 4 filed Mar 4, 2025
- 16SEC EDGARForm 4 filed Mar 3, 2025
- 17SEC EDGARForm 4 filed Jun 12, 2024
- 18SEC EDGARForm 4 filed Mar 5, 2024
- 19SEC EDGARForm 4 filed Feb 9, 2024
- 20SEC EDGARForm 4 filed Feb 2, 2024
- 21SEC EDGARForm 4 filed May 5, 2023
- 22SEC EDGARForm 4 filed Mar 3, 2023